MANNATECH INC Annual Report - How They Did This Year

I’ve put together this guide to help you understand how Mannatech performed this year. Instead of digging through dense financial filings, I’ve broken down the key points so you can see the company’s health and where it’s headed.

1. What does this company do?

Mannatech is a global health and wellness company that uses a direct-selling model. They develop and sell nutritional supplements, weight management products, and skincare. Their flagship "Ambrotose® complex" is the foundation for much of their product line. A network of about 130,000 independent associates sells these products directly to consumers in 25 countries, bypassing traditional retail stores.

2. Financial performance

As of late 2025, Mannatech is a "smaller reporting company." They generated about $115 million in sales this year. This is a decrease from previous years, as the company now prioritizes profit over rapid growth. With roughly 1.9 million shares outstanding and a public market value of about $9.9 million, this is a micro-cap company. They ended the year with $12 million in cash to cover daily operations.

3. Major wins and challenges

The company’s main focus is managing risk. They have tightened their cybersecurity oversight, with the Board of Directors now monitoring digital threats directly. Because the business relies on a global network and stores sensitive data for over 100,000 customers, protecting this information is vital to maintaining their reputation and avoiding regulatory fines.

4. Financial health

Mannatech manages complex tax obligations in the U.S., Japan, South Korea, and China. They owe about $4.5 million in loans to key stakeholders and directors, with interest rates between 4% and 6%. While they have enough cash to cover their short-term bills, their health depends on managing international taxes and paying off this debt without issuing more shares, which would dilute current ownership.

5. Key risks

• Cybersecurity: A data breach could compromise the trust of their sales force and lead to significant legal costs.
• Supply Chain: They rely on a few third-party manufacturers. If these suppliers face issues, Mannatech may struggle to produce its core products.
• Regulatory/Tax: Operating in 25 countries requires navigating constantly changing tax laws and anti-pyramid scheme regulations.
• Market Concentration: About 60% of sales come from the Asia-Pacific region. If consumer sentiment or regulations shift in South Korea or Japan, the company’s revenue would be directly impacted.

6. Competitive positioning

Mannatech competes in a crowded market against giants like Herbalife and Amway. Their success depends on the loyalty of their sales associates. To keep these sellers, they offer stock options and loyalty programs. They have issued over 150,000 stock options to retain top leaders and ensure steady, long-term sales.

7. Leadership and governance

The Board of Directors is taking a hands-on role in managing risks. The company appointed a new Chairman and a new Chief Financial Officer in early 2026. These changes aim to simplify financial reporting and improve internal controls, signaling a focus on stability during this period of flat growth.

8. Future outlook

The company is currently focused on stability rather than risky expansion. They are cutting costs and focusing on their most profitable markets. As an investor, watch to see if they can maintain this lean structure and whether they can successfully pay down their $4.5 million debt over the next 12 to 18 months.